ArticleAmerican journal of hematology2025

Third-Generation Bruton tyrosine kinase Inhibitors for the Treatment of Monoclonal Gammopathy of Thrombotic Significance (MGTS).

Louise Man et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.